Results 201 to 207 of about 4,852 (207)

Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

New England Journal of Medicine, 2015
Jeanne M Marrazzo, Gonasagrie Nair, Ariane van der Straten   +2 more
exaly  

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide: perhaps not as simple as we thought

The Lancet Gastroenterology & Hepatology, 2020
openaire   +2 more sources

Bictegravir/emtricitabine/tenofovir-alafenamide/Doravirine/lamivudine/tenofovir-disoproxil-fumarate

Reactions Weekly
openaire   +1 more source

Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence

American Journal of Kidney Diseases, 2011
Andrew M Hall, Dorothea Nitsch
exaly  

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy

Antimicrobial Agents and Chemotherapy, 2018
Peter L Anderson, Albert Y Liu, Jose R Castillo-Mancilla   +2 more
exaly  

Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study

Clinical Infectious Diseases, 2020
exaly  

Which Form of Tenofovir Should Be Used Worldwide: Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide?

Clinical Infectious Diseases
openaire   +2 more sources